As worries about populism in Europe rise, investors bet on stock market volatility
March 22, 2019Asian shares firm after solid U.S. data, tech sector hopes
March 22, 2019Shares of Japan’s Eisai swamped with sell orders after ending Alzheimer trials
at
Eisai Co Ltd’s shares were untraded on Friday, hit with a glut of sell orders after the Japanese drugmaker and its partner Biogen Inc said they are ending two drug trials of their experimental Alzheimer’s disease drug aducanumab.
Powered by WPeMatico
